Aerovate Therapeutics, Inc.
AVTE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$69,628 | -$75,521 | -$51,511 | -$22,963 |
| Dep. & Amort. | $282 | $96 | $68 | $15 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $11,311 | $11,906 | $5,476 | $2,043 |
| Change in WC | -$11,169 | $9,798 | $7,755 | -$6,510 |
| Other Non-Cash | -$1,992 | -$3,057 | -$910 | $16 |
| Operating Cash Flow | -$71,196 | -$56,778 | -$39,122 | -$27,399 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$142 | -$195 | -$181 |
| Net Acquisitions | $0 | $0 | -$7 | $0 |
| Inv. Purchases | -$19,683 | -$123,982 | -$147,623 | -$113,253 |
| Inv. Sales/Matur. | $75,712 | $136,000 | $154,744 | $0 |
| Other Inv. Act. | $0 | $0 | $7 | -$113 |
| Investing Cash Flow | $56,029 | $11,876 | $6,926 | -$113,434 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $23,942 | $44,888 | $150 | $126,945 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1,485 | $2,216 | $396 | $63,512 |
| Financing Cash Flow | $25,427 | $45,996 | $396 | $190,457 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $10,260 | $1,094 | -$31,800 | $49,624 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $23,491 | $22,397 | $54,197 | $4,573 |
| End Cash | $33,751 | $23,491 | $22,397 | $54,197 |
| Free Cash Flow | -$71,196 | -$56,920 | -$39,317 | -$27,580 |